Yue Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yue Yuan has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Xinlong Wang
School of Pharmacy, Shenyang Key Laboratory of Functional Drug Carrier Materials, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
10 shared publicationsJiani Zheng
Shenyang Key Laboratory of Functional Drug Carrier Materials, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, PR China
8 shared publicationsBing Hu
School of Pharmacy, Shenyang Key Laboratory of Functional Drug Carrier Materials, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
6 shared publicationsZhaofei Yang
6 shared publicationsHaitao Zhu
5 shared publicationsKaili Wang
School of Pharmacy, Shenyang Key Laboratory of Functional Drug Carrier Materials, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
5 shared publications
Latest Publications
- 15 May 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 699, 126983
Self-enhanced copper-doped Prussian blue nanoplatform for amplifying enzyme-like activity and photothermal effects
- 15 May 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 699, 126983
Self-enhanced copper-doped Prussian blue nanoplatform for amplifying enzyme-like activity and photothermal effects
- 14 April 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 185, 214887
pH-gated dual-modal switch photothermal cascade nanozyme hydrogel for diabetic infectious wound healing
- 14 April 2026
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 185, 214887
pH-gated dual-modal switch photothermal cascade nanozyme hydrogel for diabetic infectious wound healing
- 2 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (14) , 20146-20158
A Multifunctional Nanocomposite Hydrogel Platform with a Sequentially Coordinated Strategy for Infected Wound Healing
Effective healing of infected wounds is hindered by the inability of single-function materials to dynamically address the distinct biological phases of infection control and tissue regeneration. Herein, we present a versatile drug-loaded nanocomposite hydrogel platform (ML-OCP) that employs a sequentially coordinated strategy for efficient infected wound repair. The ML-OCP hydrogel was fabricated by incorporating l-arginine-loaded mesoporous polydopamine nanoparticles (MPDA@l-Arg NPs) into a dual-network matrix, which was formed through the Schiff base linkage between oxidized hyaluronic acid (OHA) and carboxymethyl chitosan (CMCS), along with hydrogen bonding from polyvinylpyrrolidone (PVP). ML-OCP hydrogel exhibits excellent tissue adhesiveness, self-healing ability, and mechanical properties, enabling its adaptation to the dynamic wound environment and rapid hemostasis. Building upon this stable foundation, the hydrogel implements a sequentially coordinated therapeutic strategy: the MPDA@l-Arg NPs provide immediate antibacterial (via photothermal therapy, PTT) and antioxidant actions to control early infection, while the sustained release of l-arginine ensures continuous bioactive support for the subsequent proliferation and remodeling. In a rat model of infected full-thickness skin defect, ML-OCP hydrogel demonstrated significant antibacterial activity, promoted angiogenesis, and reduced inflammation. Collectively, this work provides a versatile hydrogel platform based on a sequentially coordinated strategy, offering a new therapeutic approach for infected wounds.
- 2 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (14) , 20146-20158
A Multifunctional Nanocomposite Hydrogel Platform with a Sequentially Coordinated Strategy for Infected Wound Healing
Effective healing of infected wounds is hindered by the inability of single-function materials to dynamically address the distinct biological phases of infection control and tissue regeneration. Herein, we present a versatile drug-loaded nanocomposite hydrogel platform (ML-OCP) that employs a sequentially coordinated strategy for efficient infected wound repair. The ML-OCP hydrogel was fabricated by incorporating l-arginine-loaded mesoporous polydopamine nanoparticles (MPDA@l-Arg NPs) into a dual-network matrix, which was formed through the Schiff base linkage between oxidized hyaluronic acid (OHA) and carboxymethyl chitosan (CMCS), along with hydrogen bonding from polyvinylpyrrolidone (PVP). ML-OCP hydrogel exhibits excellent tissue adhesiveness, self-healing ability, and mechanical properties, enabling its adaptation to the dynamic wound environment and rapid hemostasis. Building upon this stable foundation, the hydrogel implements a sequentially coordinated therapeutic strategy: the MPDA@l-Arg NPs provide immediate antibacterial (via photothermal therapy, PTT) and antioxidant actions to control early infection, while the sustained release of l-arginine ensures continuous bioactive support for the subsequent proliferation and remodeling. In a rat model of infected full-thickness skin defect, ML-OCP hydrogel demonstrated significant antibacterial activity, promoted angiogenesis, and reduced inflammation. Collectively, this work provides a versatile hydrogel platform based on a sequentially coordinated strategy, offering a new therapeutic approach for infected wounds.
- 7 February 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 347, 150707
Corrigendum to “Dual dynamic covalent hydrogel enabling pH-responsive release of carboxymethyl chitosan and caffeic acid for synergistic antibacterial activity and wound healing” [Int. J. Biol. Macromol. 338 (2026) 149785]
- 7 February 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 347, 150707
Corrigendum to “Dual dynamic covalent hydrogel enabling pH-responsive release of carboxymethyl chitosan and caffeic acid for synergistic antibacterial activity and wound healing” [Int. J. Biol. Macromol. 338 (2026) 149785]
- 18 December 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 338 (Pt 2) , 149785
Dual dynamic covalent hydrogel enabling pH-responsive release of carboxymethyl chitosan and caffeic acid for synergistic antibacterial activity and wound healing
- 18 December 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 338 (Pt 2) , 149785
Dual dynamic covalent hydrogel enabling pH-responsive release of carboxymethyl chitosan and caffeic acid for synergistic antibacterial activity and wound healing
- 21 October 2024
- Published by Elsevier in Carbohydrate Polymers
- Vol. 348 (Pt B) , 122894
Glucose-activated self-cascade antibacterial and pro-angiogenesis nanozyme-functionalized chitosan-arginine thermosensitive hydrogel for chronic diabetic wounds healing
- 21 October 2024
- Published by Elsevier in Carbohydrate Polymers
- Vol. 348 (Pt B) , 122894
Glucose-activated self-cascade antibacterial and pro-angiogenesis nanozyme-functionalized chitosan-arginine thermosensitive hydrogel for chronic diabetic wounds healing
- 28 February 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 368, 219-232
Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis
- 28 February 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 368, 219-232
Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis